|
시장보고서
상품코드
2053278
호흡기질환 검사 시장 : 검사 유형별, 최종 사용자별, 지역별Respiratory Disease Testing Market, By Test Type, By End User, and By Region |
||||||
호흡기질환 검사 시장은 2026년에 36억 4,260만 달러로 추계되고 있으며, 2033년까지 48억 5,830만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR 4.2%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모 : 2026년 | 36억 4,260만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간 CAGR : 2026-2033년 | 4.20% | 시장 규모 예측 : 2033년 | 48억 5,830만 달러 |
호흡기 진단이란, 환자의 호흡기 질환이나 장애를 진단하기 위해 사용되는 의료 제품 및 기술을 말합니다. 호흡기 진단은 질환을 조기에 발견할 수 있어 효과적입니다. 호흡기 질환이란 호흡과 관련된 구조나 장기에 영향을 미치는 병증을 말합니다. 해부학적 특징에 따라 호흡기는 상기도와 하기도로 분류됩니다. 상기도는 인두, 후두, 비강으로 구성되며, 하기도는 기관, 폐, 기관지를 포함합니다. 호흡기 질환, 즉 폐 질환에는 천식, 낭포성 섬유증, 폐기종, 폐암, 중피종, 폐고혈압, 결핵 등의 질환이 포함됩니다. 치료를 소홀히 할 경우, 폐 질환은 건강상의 합병증, 심각한 증상, 나아가 생명을 위협하는 상태를 초래할 수 있습니다.
시장 역학
제품 출시, 승인, 인수, 합병 등의 개발 활동이 시장 전체의 성장을 주도하고 있습니다. 예를 들어, 2022년 11월, 인도의 다국적 제약 기업인 Cipla Limited는 세계 COPD의 날을 맞아 인도 최초로 폐활량 측정 기술(pneumotach)을 적용한 휴대용 무선 폐활량계 ‘Spirofy’를 출시했습니다. 이 회사는 이번 출시를 통해 인도 내 폐쇄성 기도 질환(OAD) 진단 분야에 혁신을 일으키는 것을 목표로 하고 있습니다. 이러한 추세는 예측 기간 동안 시장 성장에 기여할 것으로 예측됩니다. 예를 들어, 2022년 9월, 종양학, 면역학, 감염병, 안과, 중추신경계 질환 치료제를 제조하는 로슈(Roche)는 체외 진단 및 조직 기반 암 진단 분야도 전문으로 하고 있으며, 일반적인 호흡기 병원체를 동시에 검출 및 감별하기 위한 3가지 분자 중합효소연쇄반응(PCR) 진단 테스트 패널을 출시했습니다. 따라서, 이 부문에서 이루어진 이러한 진전이 부문의 성장을 견인할 것으로 예측됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략)를 바탕으로 전 세계 호흡기 질환 검사 시장의 주요 기업 프로파일을 작성하였습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 호흡기 질환 검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 호흡기질환 검사 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 호흡기질환 검사 시장 : 검사 유형별(2021-2033년)
제5장 세계의 호흡기질환 검사 시장 : 최종 사용자별(2021-2033년)
제6장 세계의 호흡기질환 검사 시장 : 지역별(2021-2033년)
제7장 기업 개요
제8장 섹션
AJY 26.06.17Respiratory Disease Testing Market is estimated to be valued at USD 3,642.6 Mn in 2026 and is expected to reach USD 4,858.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3,642.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.20% | 2033 Value Projection: | USD 4,858.3 Mn |
Respiratory diagnostics are the medical products and technologies that are used to diagnose respiratory diseases and disorders in patients. Respiratory diagnostics is effective as it can diagnose diseases at an early stage. Respiratory disease is a medical condition that affects the structure and organs associated with respiration or breathing. Based on anatomical features, the respiratory system has been segmented into the upper respiratory tract and lower respiratory tract. The upper respiratory tract comprises the pharynx, larynx, and nasal passages, while the lower respiratory tract includes the trachea, lungs, and bronchi. Respiratory disorders, or lung diseases, are disorders such as asthma, cystic fibrosis, emphysema, lung cancer, mesothelioma, pulmonary hypertension, and tuberculosis. If left untreated, lung disease can produce health complications, problematic symptoms, and life-threatening conditions.
Market Dynamics
Development activities such as product launches, approvals, acquisitions, and mergers, among other, are driving the overall market growth. For instance, in November 2022, Cipla Limited, an multinational pharmaceutical company in India, launched Spirofy, India's pneumotach-based portable, wireless Spirometer, on World COPD Day. With this launch, the company intends to revolutionize Obstructive Airway Disease (OAD) diagnosis in India. Such developments are anticipated to contribute to the market growth over the forecast period. For instance, in September 2022, Roche, manufacturing medicines in oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. Roche which also specializes in in vitro diagnostics and tissue-based cancer diagnostics, launched three molecular polymerase chain reaction (PCR) diagnostic test panels to simultaneously detect and differentiate common respiratory pathogens. Therefore, such advancements in the segment are expected to fuel segment growth.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global respiratory disease testing market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include CareFusion Corporation, Carestream Health, Inc., COSMED, Futuremed America, Inc., GE Healthcare, MGC Diagnostics Corporation, ndd Medical Technologies, Inc., Nihon Kohden Corporation, Perkin Elmer, Inc., FUJIFILM Healthcare Corporation, Philips Healthcare,Roche Healthcare, Beckton Dickinson and Company, Koninklijke Philips N.V. ResMed Inc., Medtronic, Abbott Diagnostics, and Quest Diagnostics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global respiratory disease testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global respiratory disease testing.
Market Segmentation
- Global Respiratory Disease Testing Market, By Test Type (Revenue, USD Mn, 2021 - 2033)
- Imaging Test
- Spirometry
- Peak Flow Test
- Blood Gas Test
- Lung Volume Test
- Others
- Global Respiratory Disease Testing Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Physician Offices
- Clinical Laboratories
- Global Respiratory Disease Testing Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players Insights
- CareFusion Corporation
- Carestream Health, Inc.
- COSMED, Futuremed America, Inc.
- GE Healthcare
- MGC Diagnostics Corporation
- ndd Medical Technologies, Inc.
- Nihon Kohden Corporation
- Perkin Elmer, Inc.
- FUJIFILM Healthcare Corporation
- Philips Healthcare
- Roche Healthcare
- Beckton Dickinson and Company
- Koninklijke Philips N.V. ResMed Inc.
- Medtronic
- Abbott Diagnostics
- Quest Diagnostics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaboration
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Respiratory disease testing Market, By Test Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Imaging Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Spirometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Peak Flow Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Blood Gas Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Lung Volume Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Respiratory disease testing Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Physician Offices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Clinical Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Respiratory disease testing Market, By Region, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- North America
- Market Size and Forecast, By Test Type, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Test Type, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Test Type, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Test Type, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, By Test Type, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Test Type, 2021-2033, (USD Mn)
- Market Size and Forecast, By End User, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country/Region, 2021-2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
- Rest of Africa
7. Company Profiles
- CareFusion Corporation
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Carestream Health, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- COSMED
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Futuremed America, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GE Healthcare
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MGC Diagnostics Corporation
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- ndd Medical Technologies, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nihon Kohden Corporation
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Perkin Elmer, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- FUJIFILM Healthcare Corporation
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Philips Healthcare
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Roche Healthcare
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Beckton Dickinson and Company
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Koninklijke Philips N.V.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- ResMed Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Medtronic
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Abbott Diagnostics
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Quest Diagnostics
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
8. Section
- References
- Research Methodology
- About us and Sales Contact
